BR9611477A - Polipeptìdeo ou glicopeptìdeo, composições aptas a estimular a imunidade, sequência, e vetor, de ácidos nucleicos, vetor de expressão, processo de preparação de um polipeptìdeo ou glicopeptìdeo, vacina polivalente contr5a o vìrus da dengue e composição antigênica - Google Patents

Polipeptìdeo ou glicopeptìdeo, composições aptas a estimular a imunidade, sequência, e vetor, de ácidos nucleicos, vetor de expressão, processo de preparação de um polipeptìdeo ou glicopeptìdeo, vacina polivalente contr5a o vìrus da dengue e composição antigênica

Info

Publication number
BR9611477A
BR9611477A BR9611477-0A BR9611477A BR9611477A BR 9611477 A BR9611477 A BR 9611477A BR 9611477 A BR9611477 A BR 9611477A BR 9611477 A BR9611477 A BR 9611477A
Authority
BR
Brazil
Prior art keywords
glycopeptide
polypeptide
vector
sequence
nucleic acids
Prior art date
Application number
BR9611477-0A
Other languages
English (en)
Inventor
Vincent Deubel
Isabelle Staropoli
Original Assignee
Pasteur Institut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Institut filed Critical Pasteur Institut
Publication of BR9611477A publication Critical patent/BR9611477A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/08—RNA viruses
    • C07K14/18—Togaviridae; Flaviviridae
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/14011—Baculoviridae
    • C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
    • C12N2710/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

"POLIPEPTìDEO OU GLICOPEPTìDEO, COMPOSIçõES APTAS A ESTIMULAR A IMUNIDADE, SEQUêNCIA, E VETOR, DE áCIDOS NUCLEICOS, VETOR DE EXPRESSãO, PROCESSO DE PREPARAçãO DE UM POLIPEPTìDEO OU GLICOPEPTìDEO, VACINA POLIVALENTE CONTRA O VìRUS DA DENGUE E COMPOSIçãO ANTIGêNICA". Vacina subunidade polivalente contra Flaviviridiae, especialmente contra o vírus da dengue, compreendendo peptídeos recombinantes, originados de cada serotipo, cuja extremidade carboxilada está substituída por um peptídeo contendo 2 a 8 histidinas, triptófanos ou cisteínas.
BR9611477-0A 1995-11-14 1996-11-14 Polipeptìdeo ou glicopeptìdeo, composições aptas a estimular a imunidade, sequência, e vetor, de ácidos nucleicos, vetor de expressão, processo de preparação de um polipeptìdeo ou glicopeptìdeo, vacina polivalente contr5a o vìrus da dengue e composição antigênica BR9611477A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9513489A FR2741077B1 (fr) 1995-11-14 1995-11-14 Vaccin polyvalent anti-dengue
PCT/FR1996/001801 WO1997018311A1 (fr) 1995-11-14 1996-11-14 Vaccin polyvalent anti-dengue

Publications (1)

Publication Number Publication Date
BR9611477A true BR9611477A (pt) 1999-12-28

Family

ID=9484557

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9611477-0A BR9611477A (pt) 1995-11-14 1996-11-14 Polipeptìdeo ou glicopeptìdeo, composições aptas a estimular a imunidade, sequência, e vetor, de ácidos nucleicos, vetor de expressão, processo de preparação de um polipeptìdeo ou glicopeptìdeo, vacina polivalente contr5a o vìrus da dengue e composição antigênica

Country Status (9)

Country Link
EP (1) EP0861324A1 (pt)
JP (1) JP2000500969A (pt)
KR (1) KR19990067581A (pt)
CN (1) CN1202201A (pt)
AU (1) AU718740B2 (pt)
BR (1) BR9611477A (pt)
CA (1) CA2235334A1 (pt)
FR (1) FR2741077B1 (pt)
WO (1) WO1997018311A1 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6455509B1 (en) * 1996-06-04 2002-09-24 The United States Of America As Represented By The Secretary Of The Navy Dengue nucleic acid vaccines that induce neutralizing antibodies
EP1005363B1 (en) * 1997-07-31 2006-03-29 Hawaii Biotech, Inc. Recombinant dimeric envelope vaccine against flaviviral infection
FR2767324B1 (fr) * 1997-08-14 2001-04-06 Pasteur Institut Utilisation de proteines d'enveloppe recombinantes pour le diagnostic du virus de la dengue
US6432411B1 (en) * 1999-07-13 2002-08-13 Hawaii Biotechnology Group Recombinant envelope vaccine against flavivirus infection
RU2288266C2 (ru) * 2000-02-10 2006-11-27 Зе Гавернмент Оф Зе Юнайтед Стэйтс Оф Америка, Эз Репрезентед Бай Зе Секретэри, Департмент Оф Хелс Энд Хьюмэн Сервисиз ИНФЕКЦИОННЫЕ КЛОНЫ ПОЛНОМЕРНОЙ кДНК КЛЕЩЕВОГО ФЛАВИВИРУСА
AU2010256845B2 (en) * 2009-06-01 2016-09-22 Takeda Vaccines, Inc. Compositions and methods for administration of vaccines against dengue virus
RS61000B1 (sr) * 2014-09-01 2020-11-30 Int Centre For Genetic Engineering And Biotechnology Vakcina
CN106999564A (zh) * 2014-09-02 2017-08-01 赛诺菲巴斯德有限公司 针对登革热病毒疾病的疫苗组合物
CN106290847A (zh) * 2015-05-13 2017-01-04 上海凯创生物技术有限公司 一种登革热病毒ns1抗原乳胶法检测试剂盒

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992003161A1 (en) * 1990-08-27 1992-03-05 The United States Of America, Represented By The Secretary, United States Department Of Commerce Flavivirus envelope proteins with increased immunogenicity for use in immunization against virus infection
US5843752A (en) * 1995-05-12 1998-12-01 Schering Corporation Soluble active hepatitis C virus protease

Also Published As

Publication number Publication date
KR19990067581A (ko) 1999-08-25
CN1202201A (zh) 1998-12-16
AU7628696A (en) 1997-06-05
CA2235334A1 (fr) 1997-05-22
FR2741077B1 (fr) 1998-01-23
FR2741077A1 (fr) 1997-05-16
AU718740B2 (en) 2000-04-20
EP0861324A1 (fr) 1998-09-02
JP2000500969A (ja) 2000-02-02
WO1997018311A1 (fr) 1997-05-22

Similar Documents

Publication Publication Date Title
DE69829668D1 (de) Herstellung und verwendung von rekombinanten influenza a virus m2 konstruktionen und impstoffe
Kilbourne et al. Influenza Virus Polypeptides and Antigens: Summary of Influeza Workshop I
AU2196592A (en) Causative agent of the mystery swine disease, vaccine compositions and diagnostic kits
MA24638A1 (fr) Vaccin
ES8704350A1 (es) Procedimiento para la preparacion de un conjugado bacteriano
CA2224724A1 (en) Subunit vaccine against flavivirus infection
BR9611477A (pt) Polipeptìdeo ou glicopeptìdeo, composições aptas a estimular a imunidade, sequência, e vetor, de ácidos nucleicos, vetor de expressão, processo de preparação de um polipeptìdeo ou glicopeptìdeo, vacina polivalente contr5a o vìrus da dengue e composição antigênica
AU4622693A (en) Potentiation of immunogenic response
BR0111366A (pt) Vacina de poxvìrus recombinante do vìrus da sìndrome respiratória e reprodutiva de porcino (prrsv)
BR9810907A (pt) Anticorpos monoclonais e policlonais, peptìdeo suscetìvel de gerar um anticorpo, agente imunogênico, sequência de nucleotìdeos, composição farmacêutica, uso de pelo menos um anticorpo, kit de diagnóstico, e, processo para preparar um agente imunogênico
ES8500997A1 (es) Un metodo para producir un peptido.
WO1989002277A3 (en) Prophylaxis and therapy of acquired immunodeficiency syndrome
CN1610697A (zh) 戊型肝炎病毒单克隆抗体或其结合活性片段及其用途
BR9812240A (pt) Proteìna g alterada ou polipeptìdeo do rsv, uso da mesma, molécula de ácido nucleico codificando uma proteìna g alterada ou um polipeptìdeo do rsv, construção do ácido nucleico, célula hospedeira recombinante, processos de produção de uma proteìna g alterada ou polipeptìdeo do rsv composição imunogênica, de indução de uma resposta imune em um vertebrado, de inibir a indução do aumento da doença após a vacinação e subsequente infecção de um vertebrado com o rsv e de imunização de um vertebrado contra o rsv, composição de vacina, vacina, e, composição imunogênica
ATE157258T1 (de) Zubereitungen und behandlungen von pneumonia in tieren
CA2121559A1 (en) Immunogenic artificial polypeptide
WO1993015763A1 (en) Vaccinal polypeptides
KR860001882A (ko) 왁진 효능이 있는 폴리펩타이드
ATE435034T1 (de) Expression und charakterisierung eines hiv-1 hüllproteins, das mit einer breitreaktiven neutralisierenden antikörperantwort assoziiert ist.
NZ507983A (en) A polypeptide comprising the amino acid of an n- terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof
DK527187A (da) Gonadoliberin-analoge, fremgangsmaade til deres fremstilling samt deres anvendelse som laegemidler
PE20010237A1 (es) GEN DERIVADO DE LAWSONIA Y POLIPEPTIDOS OmpH, PEPTIDOS Y PROTEINAS RELACIONADOS Y SUS USOS
ATE154244T1 (de) Induzierung eines schutzes gegen virale infektionen
BRPI0417286A (pt) misturas de peptìdeos ou polipeptìdeo antigênicos, peptìdeos antigênicos, polipeptìdeo antigênico, misturas antigênicas, lipopeptìdeo, mixotopo, lipomixotopo, conjugado, composições imunogênicas, vacina contra malária, uso de uma mistura, soro policlonal, anticorpo humano recombinante, usos de uma composição, medicamento, métodos e kits para o diagnóstico in vitro de malária, seqüências de nucleotìdeo, vetor de clonagem e/ou expressão recombinante, uso de um vetor de expressão vacina de dna e célula hospedeira recombinante
NO20014891D0 (no) Fragmenter av virusprotein 2 eller 3 fra polyomavirus, anvendt for transportering av aktive ingredienser

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law